Fluoxymesterone, also known as CR1447 or 4-hydroxytestosterone (4-OHT), is an androgen receptor modulator that exerts antiproliferative effects in ER + ve and ER-ve/AR+ ve breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.